Gynecologic Oncologists Highlight Ongoing Areas of Exploration Throughout the Treatment Armamentarium
Michael P. Stany, MD, discusses the optimization of PARP inhibitors in the upfront maintenance setting of ovarian cancer, the benefit of novel targets and immunotherapy combinations, and the role of immunotherapy in the treatment of advanced endometrial cancer.
Source: onclive.com